US Stock MarketDetailed Quotes
TNXP Tonix Pharmaceuticals
- 0.1311
- -0.0089-6.36%
Close Nov 15 16:00 ET
- 0.1330
- +0.0019+1.45%
Post 19:59 ET
24.50MMarket Cap-1P/E (TTM)
0.1402High0.1286Low10.51MVolume0.1402Open0.1400Pre Close1.39MTurnover5.62%Turnover Ratio0.00P/E (Static)186.89MShares22.137652wk High0.33P/B24.50MFloat Cap0.118052wk Low--Dividend TTM186.89MShs Float263679868.1600Historical High--Div YieldTTM8.29%Amplitude0.1180Historical Low0.1320Avg Price1Lot Size
Tonix Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.21M | 2.48M | 7.77M | 3.78M | 3.99M | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --2.21M | --2.48M | --7.77M | --3.78M | --3.99M | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 3.37M | 1.66M | 4.74M | 2.37M | 2.37M | 0 | 0 | 0 | 0 | 0 |
| Gross profit | -1.16M | 822K | 3.03M | 1.41M | 1.62M | 0 | 0 | 0 | 0 | 0 |
| Operating expense | -40.69%17.2M | -34.60%22.17M | 8.31%121.41M | -12.18%28.74M | 0.58%29.76M | 24.28%29M | 28.24%33.9M | 21.43%112.09M | 11.02%32.73M | 59.65%29.59M |
| Selling and administrative expenses | 6.77%7.5M | 25.96%9.31M | 15.02%34.75M | 44.29%11.62M | 17.89%8.71M | 3.98%7.03M | -7.77%7.39M | 28.72%30.22M | 12.13%8.05M | 35.52%7.39M |
| -General and administrative expense | 6.77%7.5M | 25.96%9.31M | 15.02%34.75M | ---- | ---- | 3.98%7.03M | -7.77%7.39M | 28.72%30.22M | ---- | ---- |
| Research and development costs | -55.87%9.7M | -51.48%12.86M | 5.84%86.66M | -30.62%17.12M | -5.18%21.05M | 32.55%21.98M | 43.91%26.51M | 18.94%81.88M | 10.67%24.67M | 69.71%22.2M |
| Operating profit | 36.70%-18.36M | 37.02%-21.35M | -5.61%-118.38M | 16.50%-27.33M | 4.88%-28.15M | -24.28%-29M | -28.24%-33.9M | -21.43%-112.09M | -11.02%-32.73M | -59.65%-29.59M |
| Net non-operating interest income expense | -71.80%172K | 8,614.29%610K | ||||||||
| Non-operating interest income | ---- | ---- | ---- | ---- | -71.80%172K | ---- | ---- | ---- | ---- | 8,614.29%610K |
| Other net income (expense) | -9,452.48%-60.42M | 614.83%6.41M | -8.06%1.72M | 646K | 897K | 1.87M | ||||
| Gain on sale of security | ---855K | --7.01M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | ---58.96M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | --58.96M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | -193.65%-605K | -166.11%-593K | -8.06%1.72M | ---- | ---- | --646K | --897K | --1.87M | ---- | ---- |
| Income before tax | -177.81%-78.78M | 54.74%-14.94M | -5.84%-116.66M | 13.76%-27.32M | 3.47%-27.98M | -22.54%-28.36M | -24.94%-33.01M | -19.43%-110.22M | -7.20%-31.68M | -56.42%-28.98M |
| Income tax | ||||||||||
| Net income | -177.81%-78.78M | 54.74%-14.94M | -5.84%-116.66M | 13.76%-27.32M | 3.47%-27.98M | -22.54%-28.36M | -24.94%-33.01M | -19.43%-110.22M | -7.20%-31.68M | -56.42%-28.98M |
| Net income continuous Operations | -177.81%-78.78M | 54.74%-14.94M | -5.84%-116.66M | 13.76%-27.32M | 3.47%-27.98M | -22.54%-28.36M | -24.94%-33.01M | -19.43%-110.22M | -7.20%-31.68M | -56.42%-28.98M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -177.81%-78.78M | 54.74%-14.94M | -5.84%-116.66M | 13.76%-27.32M | 3.47%-27.98M | -22.54%-28.36M | -24.94%-33.01M | -19.43%-110.22M | -7.20%-31.68M | -56.42%-28.98M |
| Preferred stock dividends | 6.66M | 2.4M | ||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -177.81%-78.78M | 54.74%-14.94M | 0.19%-116.66M | 19.84%-27.32M | 3.47%-27.98M | -3.51%-28.36M | -24.94%-33.01M | -26.65%-116.88M | -15.33%-34.08M | -56.42%-28.98M |
| Basic earnings per share | 60.84%-19.28 | 94.39%-5.76 | 65.77%-219.2 | 86.68%-14.9161 | 56.84%-58.56 | 79.86%-49.23 | 68.10%-102.72 | 60.47%-640.32 | 75.00%-112 | 57.60%-135.68 |
| Diluted earnings per share | 60.84%-19.28 | 94.39%-5.76 | 65.77%-219.2 | 86.68%-14.9161 | 56.84%-58.56 | 79.86%-49.23 | 68.10%-102.72 | 60.47%-640.32 | 75.00%-112 | 57.60%-135.68 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
